The role of inflammation factors in development of acute coronary syndrome in patients with type 2 diabetes mellitus and impaired glucose tolerance

Terapevticheskii Arkhiv

Volumn 79, Issue 6, 2007, Pages 60-64

  Chazova, T E ^a   Masenko, V P ^a   Zykov, K A ^a   Golitsyna, T Yu ^a  

^a NONE

Author keywords

Acute coronary syndrome; Depression; Diabetes mellitus; Inflammatory markers

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CCL2 PROTEIN, HUMAN; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 18; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CORONARY DISEASE; DEPRESSION; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34547645183     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Russian source
2. Koenig W., Lowel H., Baument J., Meisinger C. C-reactive protein modulation risk prediction based on the Framingen score implications for future risk assessment: Result from a large cohort study in Southern Germany. Circulation 2004; 109(11): 1349-1353.
3. Ridker P. M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813-1818.
4. Koenig W., Sund M., Frohlich M. et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged man: results from the MONICA (Monitoring Trends and Determinations in Cardiovascular Disease) Augsburg Cohort Study, 1984-1992. Circulation 1999; 99: 237-242.
5. Lower G. D. O., Sweeiham P. M., Yarnell J. W. G. et al. C-reactive protein, fibrin D-dimer, and risk of ishemic heart disease. The Caerphilly and Speedwell Studies. Arterioscler. Thromb. Vasc. Biol. 2004; 24(10): 1957-1962.
6. Amar J., Fauvel J., Drouet L. et al. Interleukin 6 is associated with subclinical atherosclerosis: a link with soluble intercellular adhesion molecular 1. J. Hypertens. 2006; 24(6): 1083-1088.
7. Dinarello C. A. Interleukin 1 beta and interleukin 18 as mediators of inflammation and the aging process. Am. J. Clin. Nutr. 2006; 83(2): 447S-455S.
8. Hoogeveen R. C., Morrison A., Boerwinkle F. et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities Study. Atherosclerosis 2005; 183(2): 301-307.
9. Ridker P. M., Hennekens C. H., Buring J. E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 2000; 342(12): 836-843.
10. Fogelstrand L., Hulthe J., Hulten L. M. et al. Monocyte expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia 2004; 47(11): 1948-1952.
11. Folsom A. R., Aleksic N., Catellier D. et al. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 2002; 144(2): 233-238.
12. Jager A., van Hinsbergh V. W. M., Kostense P. J. et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes. The Hoorn Study. Diabetes 2000; 49: 484-490.
13. Nakamura A., Shikata K., Hiramatsu M. et al. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis with type 2 diabetes. Diabet. Care 2005; 28(12): 2890-2895.
14. Mine S., Okada T., Nanikawa T. et al. Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem. Biophys. Res. Commun. 2006; 334(3): 780-785.
15. Pickup J. C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabet. Care 2004; 27(3): 813-823.
16. Lesperance F., Frassure-Smith N., Theroux P., Irvin M. The association between major depression and levels of soluble intercellular adhesion molecular-1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes. Am. J. Psychiatry 2004; 161(2): 271-277.
17. Russian source
18. Russian source
19. Beck A. T., Ward C. H., Mendelson M. et al. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 5: 561-571.
20. Boulbou M. S., Koukoulis G. N., Makri E. D. et al. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int. J. Cardiol. 2005; 98(1): 139-144.